Retailers continue to struggle as Bed Bath & Beyond announces plans to close more than 20% of its stores over the next two years. Levi’s sales fall more than 60% for the second quarter. Berkshire Hathaway buys Dominion Energy’s natural gas assets. SiriusXM buys Stitcher. And Kraft Heinz makes mayonnaise ice cream a reality! Motley Fool analysts Ron Gross and ... Show More
Yesterday
The Fast Casual Comeback Tour
Fast casual restaurant stocks were hit hard over the past year, but many have snapped back over the past month. In today’s episode of Motley Fool Money, Emily Flippen is joined by Fool analysts Sanmeet Deo and Jason Hall to break down what has caused the rebound, how consumer tas ... Show More
22m 43s
Apr 2024
Fed Decision Kick-Off, Amazon and Apple Results, and Busiest Week of Earnings Season 4/29/24
<p>Investors are awaiting the kickoff to this week's Fed decision. The Milken Institute's Bill Lee gives his expectations. Plus, Amazon and Apple are set to deliver results in what could be two market-moving events. Janus Henderson's Alison Porter explains. And, it's busiest week ... Show More
42m 36s
Jun 2021
The Last Trading Day of a Bullish First Half, China's Didi Leads the IPO Parade, Apple vs. Employees on Work-From-Home, Revising a "Momentus" SPAC deal, and Biden vs. Big Business?
Carl Quintanilla, Jim Cramer and David Faber explored the road ahead for stocks on the final trading day of the month, quarter and first half of the year -- the S&P 500 on track for its best 1H since 2019.
Cramer explains why he prefers semiconductor stocks such as Nvidia and AMD ... Show More
44m 39s
Nov 2021
Market Reaction to COVID Lockdowns and Developments, a Record High for the Nasdaq, The EV Space’s Week for the Ages and the House Passes Pres. Biden's $1.7T Social Spending Package
Carl Quintanilla, Jim Cramer and David Faber discussed market worries about COVID-19, with Austria announcing a nationwide lockdown while Germany tried to tamp down fears that it would follow suit. But in the U.S., FDA authorized use of Pfizer and Moderna's COVID vaccine booster ... Show More
45m 31s
Jan 2024
Hayfin Expects Private-Debt M&A; BI on Ozempic Risks
Private-debt firms are set to consolidate as larger companies dominate deal flow, according to Marc Chowrimootoo, portfolio manager at Hayfin Capital Management. “We’re seeing a concentration within fewer hands,” Chowrimootoo tells Bloomberg News’ Lisa Lee and James Crombie and B ... Show More
33m 35s
Sep 2021
Tech Stock Sell-off, Carl at the Code Conference, Countdown to Powell and Yellen on the Hill, Ford's $11.4B bet on EVs, and the CEO of Robinhood Fires Back At Critics
Jim Cramer and David Faber led off with a rough start for the markets: Tech stocks in sell-off mode as the 10-year note yield hits a fresh three-month high. Jim and David focused on the mega-cap tech names and whether now is the time to buy. Speaking of tech: At the Code Conferen ... Show More
43m 20s
Jan 2022
Close to a Buyable Bottom?
Scott Wapner and the Investment Committee discuss the turbulent week for stocks and how you should navigate the ups and downs of the current market. Plus, MBF Founder and CEO Mark Fisher joins us to talk energy, what does the future hold for the sector. And later, Jim Lebenthal ... Show More
47m 16s